Parker Waichman LLP Announces Investigation into Multiple Sclerosis Drug That Can Cause Stroke or Death Nationally renowned drug-defect attorneys Parker Waichman LLP announce that their firm has opened an investigation into the Multiple Sclerosis (MS) drug Lemtrada (alemtuzumab) and its potential to cause the MS patient to suffer a … [Read more...] about Multiple Sclerosis Drug That Can Cause Stroke or Death

The U.S. Food and Drug Administration (FDA) announced that the drug Lemtrada, also known as Campath (alemtuzumab), carries with it the chance that a patient suffering from relapsing multiple sclerosis (MS) may experience a stroke. The FDA said in its press release dated November 29, 2018 that all alemtuzumab drugs like Lemtrada must … [Read more...] about MS Drug Lemtrada Linked to Strokes, Death